It still never ceases to amaze me how quickly stocks fall in and out of fashion with investors, traders and market participants.
Indeed, the healthcare/ biotech sector has taken another serious pasting today following worse-than-expected figures from Roche, the Swiss pharmaceutical giant. So, AstraZeneca is down 3pc today while Shire has fallen almost 5pc.
A cheeky financial blog with stories about deals, dealmakers and anything else I find interesting. Edited by Ben Harrington. [Disclaimer - the information on Betaville does not constitute any form of investment recommendation and is not intended to be relied upon by readers in making, or refraining from, any investment decisions.]
Showing posts with label MySQUAR. Show all posts
Showing posts with label MySQUAR. Show all posts
Thursday, 28 January 2016
Tuesday, 22 September 2015
Burmese Business - part 3
Shares in MySQUAR, the Burmese social media platform, have taken a bit of battering since the company floated on London's Alternative Investment Market in late Spring this year - like most stocks exposed to emerging markets.
However, I have a piece of good news for those observers that follow the company. I understand Facebook has decided to support MySQUAR and its app MyCHAT with up to $80,000 in free services and tools.
However, I have a piece of good news for those observers that follow the company. I understand Facebook has decided to support MySQUAR and its app MyCHAT with up to $80,000 in free services and tools.
Tuesday, 23 June 2015
Burmese Business - part 2
Remember that little Burmese social media company I wrote about a few weeks ago. If not, here is a link to the piece I wrote on MySQUAR to jolt your memory:
Subscribe to:
Comments (Atom)